Samarth Kulkarni - Chief Executive Officer, Director at CRISPR Therapeutics AG

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
CRSP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Samarth Kulkarni - trading volume in the past year for CRISPR Therapeutics AG

Holdings reported by Samarth Kulkarni for CRISPR Therapeutics AG

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 254K $17.3M $67.91 Oct 17, 2025 Direct
Common Shares 85.7K $5.55M $64.81 Oct 16, 2025 The Kulkarni 2023 GRAT
Restricted Stock Units 300K Oct 16, 2025 Direct Common Shares
Stock Option (Right to Buy) 49.5K Oct 3, 2025 Direct Common Shares

Transactions reported by Samarth Kulkarni for CRISPR Therapeutics AG

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.